Science Applications International Corp SAIC
Services-Computer Integrated Systems Design · CIK 0001571123 · Fiscal year ends 0129
Revenue
$1.88B
Fiscal year ended 2026-07-31Operating income
$152.00M
Fiscal year ended 2026-07-31Free cash flow
$131.00M
Fiscal year ended 2026-07-31Science Applications International Corp (SAIC) reported revenue of $1.88B and net income of $102.00M for the fiscal year ended 2026-07-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Science Applications International Corp’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Computer Integrated Systems Design.
Income
Science Applications International Corp income by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2026-07-31 | 2026-05-01 | 2026-01-30 | 2025-10-31 | 2025-08-01 | 2025-05-02 | 2025-01-31 | 2024-11-01 | 2024-08-02 | 2024-05-03 |
|---|
| Revenue | $1.88B | $1.91B | $1.75B | $1.87B | $1.77B | $1.88B | $1.84B | $1.98B | $1.82B | $1.85B |
|---|
| Cost of revenue | $1.64B | $1.66B | $1.53B | $1.64B | $1.55B | $1.67B | $1.61B | $1.74B | $1.61B | $1.63B |
|---|
| Gross profit | $239.00M | $249.00M | $221.00M | $227.00M | $215.00M | $209.00M | $232.00M | $237.00M | $210.00M | $213.00M |
|---|
| Operating income | $152.00M | $179.00M | $133.00M | $128.00M | $139.00M | $121.00M | $138.00M | $160.00M | $134.00M | $131.00M |
|---|
| Net income | $102.00M | $115.00M | —Unavailable | $78.00M | $127.00M | $68.00M | $98.00M | $106.00M | $81.00M | $77.00M |
|---|
| Research & development | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Weighted-average diluted shares | shares 42.80M | shares 44.00M | —Unavailable | shares 46.10M | shares 46.80M | shares 47.80M | —Unavailable | shares 49.80M | shares 51.20M | shares 52.10M |
|---|
| Pretax income | $119.00M | $145.00M | $99.00M | $94.00M | $108.00M | $86.00M | $107.00M | $126.00M | $100.00M | $95.00M |
|---|
| Income tax expense | $17.00M | $30.00M | $14.00M | $16.00M | -$19.00M | $18.00M | $9.00M | $20.00M | $19.00M | $18.00M |
|---|
| Diluted EPS | $2.38 | $2.61 | —Unavailable | $1.69 | $2.71 | $1.42 | —Unavailable | $2.13 | $1.58 | $1.48 |
|---|
| Selling, general & administrative | $87.00M | $83.00M | $85.00M | $101.00M | $75.00M | $89.00M | $94.00M | $83.00M | $77.00M | $85.00M |
|---|
| General & administrative | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Selling & marketing | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
Balance
Science Applications International Corp balance by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2026-07-31 | 2026-05-01 | 2026-01-30 | 2025-10-31 | 2025-08-01 | 2025-05-02 | 2025-01-31 | 2024-11-01 | 2024-08-02 | 2024-05-03 |
|---|
| Cash & equivalents | $126.00M | $109.00M | $182.00M | $45.00M | $48.00M | $47.00M | $56.00M | $46.00M | $48.00M | $49.00M |
|---|
| Total assets | $5.42B | $5.34B | $5.35B | $5.42B | $5.20B | $5.21B | $5.25B | $5.28B | $5.25B | $5.25B |
|---|
| Current assets | $1.28B | $1.20B | $1.18B | $1.26B | $1.20B | $1.15B | $1.15B | $1.16B | $1.10B | $1.09B |
|---|
| Total liabilities | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Current liabilities | $1.06B | $1.04B | $982.00M | $1.05B | $1.45B | $1.47B | $1.40B | $1.34B | $1.29B | $1.15B |
|---|
| Total equity incl. NCI | $1.44B | $1.42B | $1.50B | $1.51B | $1.52B | $1.50B | $1.58B | $1.61B | $1.62B | $1.76B |
|---|
| Temporary (mezzanine) equity | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Inventory | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Accounts receivable | $996.00M | $962.00M | $853.00M | $1.04B | $951.00M | $1.01B | $1.00B | $1.02B | $946.00M | $934.00M |
|---|
| Goodwill | $2.94B | $2.94B | $2.94B | $2.96B | $2.85B | $2.85B | $2.85B | $2.85B | $2.85B | $2.85B |
|---|
| Long-term debt | $2.45B | $2.46B | $2.47B | $2.48B | $1.84B | $1.88B | $1.91B | $1.94B | $1.97B | $1.99B |
|---|
| Accounts payable | —Unavailable | —Unavailable | $500.00M | —Unavailable | —Unavailable | —Unavailable | $631.00M | —Unavailable | —Unavailable | —Unavailable |
|---|
Cash flow
Science Applications International Corp cash flow by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2026-07-31 | 2026-05-01 | 2026-01-30 | 2025-10-31 | 2025-08-01 | 2025-05-02 | 2025-01-31 | 2024-11-01 | 2024-08-02 | 2024-05-03 |
|---|
| Operating cash flow | $146.00M | $127.00M | $258.00M | $129.00M | $122.00M | $100.00M | $115.00M | $143.00M | $138.00M | $98.00M |
|---|
| Capital expenditures | $15.00M | $9.00M | $8.00M | $9.00M | $7.00M | $8.00M | $15.00M | $9.00M | $6.00M | $6.00M |
|---|
| Investing cash flow | -$15.00M | $1.00M | -$11.00M | -$215.00M | -$7.00M | -$15.00M | -$20.00M | $1.00M | -$9.00M | -$7.00M |
|---|
| Financing cash flow | -$114.00M | -$201.00M | -$110.00M | $83.00M | -$114.00M | -$94.00M | -$85.00M | -$146.00M | -$131.00M | -$136.00M |
|---|
| Net change in cash | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Stock-based compensation | $15.00M | $13.00M | $13.00M | $26.00M | $10.00M | $15.00M | $15.00M | $13.00M | $12.00M | $13.00M |
|---|
| Common dividends paid | $16.00M | $17.00M | $17.00M | $17.00M | $17.00M | $19.00M | $18.00M | $18.00M | $19.00M | $20.00M |
|---|
| Common share repurchases | $98.00M | $188.00M | $98.00M | $95.00M | $110.00M | $142.00M | $133.00M | $121.00M | $201.00M | $103.00M |
|---|
| Depreciation & amortization | $39.00M | $40.00M | $40.00M | $38.00M | $35.00M | $36.00M | $36.00M | $35.00M | $34.00M | $35.00M |
|---|
Derived
Science Applications International Corp derived by fiscal year, in US dollars, normalized from SEC filings.| Metric | 2026-07-31 | 2026-05-01 | 2026-01-30 | 2025-10-31 | 2025-08-01 | 2025-05-02 | 2025-01-31 | 2024-11-01 | 2024-08-02 | 2024-05-03 |
|---|
| Free cash flow | $131.00M | $118.00M | $250.00M | $120.00M | $115.00M | $92.00M | $100.00M | $134.00M | $132.00M | $92.00M |
|---|
| Gross margin | 12.7% | 13.1% | 12.6% | 12.2% | 12.2% | 11.1% | 12.6% | 12.0% | 11.6% | 11.5% |
|---|
| Operating margin | 8.1% | 9.4% | 7.6% | 6.9% | 7.9% | 6.4% | 7.5% | 8.1% | 7.4% | 7.1% |
|---|
| FCF margin | 7.0% | 6.2% | 14.3% | 6.4% | 6.5% | 4.9% | 5.4% | 6.8% | 7.3% | 5.0% |
|---|
| SBC / revenue | 0.8% | 0.7% | 0.7% | 1.4% | 0.6% | 0.8% | 0.8% | 0.7% | 0.7% | 0.7% |
|---|
| Current ratio | 1.20x | 1.16x | 1.20x | 1.20x | 0.83x | 0.78x | 0.83x | 0.87x | 0.85x | 0.95x |
|---|
| Revenue YoY growth | 6.3% | 1.5% | -4.8% | -5.6% | -2.7% | 1.6% | 5.8% | 4.3% | 1.9% | -8.9% |
|---|
| Net margin | 5.4% | 6.0% | —Unavailable | 4.2% | 7.2% | 3.6% | —Unavailable | 5.4% | 4.5% | 4.2% |
|---|
| R&D / revenue | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| CapEx / revenue | 0.8% | 0.5% | 0.5% | 0.5% | 0.4% | 0.4% | 0.8% | 0.5% | 0.3% | 0.3% |
|---|
| Long-term debt / equity | 1.71x | —Unavailable | 1.65x | 1.64x | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable | —Unavailable |
|---|
| Effective tax rate | 14.3% | 20.7% | 14.1% | 17.0% | -17.6% | 20.9% | 8.4% | 15.9% | 19.0% | 18.9% |
|---|
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SAIC in the interactive workspace to inspect any figure back to its filing.
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.